ION Television

Network profile

  • Reaches 100 million-plus U.S. households
  • A top-rated network among adults 25 to 54
  • The only network with double-digit growth three years in a row
  • High commercial exposure and recall
  • Long length of tune
  • Live viewing, with minimal fast-forwarding
  • Ranked in the top 10 in more than 100 key spending categories

Integrated media opportunities

  • Creative client solutions and new state-of-the-art facilities, including studios in Tampa, Fla., and New York
  • Dedicated client solutions-management team to develop promotions tailored to your brand
  • "Flashpoint," original holiday movie and ENTV sponsorship opportunities available for fourth quarter on a variety of platforms, including on- and off-air, social, mobile and online

Contact

Lisa Fischer
Senior VP-Network Sales
212-603-8460
lisafischer@ionmedia.com

ION Television delivers quality programming, performance, engagement and consumers who spend. A leading U.S. general-entertainment network, ION combines high quality programming and dependable broadcast distribution with an attitude of innovation and growth normally associated with a cable channel. Its "Positively entertaining" network brand positioning features a formula of proven series, an expansive catalog of blockbuster movies and a commitment to introduce new original programming. ION's reach has grown to more than 100 million households, and it has become a top-rated U.S. network in record time.

ION Television is one of the fastest-growing networks in the nation. A top 10-rated network among adults 25 to 54 and women 25 to 54, ION is the only network with double-digit growth three years in a row. ION also has premium channel positioning, with 85 percent of distribution under channel 22 and 95 percent under channel 32.

ION's premium programming lineup is spearheaded by the original series "Flashpoint," which continues to show strong growth on Tuesdays at 10 p.m. ET. The series also has a greater percentage of live viewing and less commercial avoidance than any other original scripted drama on cable.

Building on a successful 2011 season, ION will premiere six new original holiday movies beginning in November.

ION's other programming hits include "Criminal Minds," the network's top-rated series, as well as "Psych," "Cold Case" and "Without a Trace." In 2012, ION will introduce the popular scripted drama "Leverage" and broadcast favorite "House."



HIGHLIGHTS


Flashpoint: ION original series premiere in fall 2011 ranked No. 9 among all cable nets and its audience grew throughout the fourth quarter. Renewed for a fifth season with 13 new episodes in 2012-13.

Criminal Minds: ION's highest-rated series, starring Thomas Gibson and Joe Mantegna; rights through 2016.

Psych: Lowered the time period median age by almost four years (51.8 to 47.9) and improved its time period by 20 percent.

Cold Case: Since debuting on ION in January 2012, each hour of the series has experienced double-digit time-period growth.

Leverage: Starring Academy Award winner Timothy Hutton, the show is one of cable's most popular original scripted dramas; coming to ION in summer 2012.

House: Joining ION's lineup in 2012. Two-time Golden Globe winner Hugh Laurie stars as the irreverent, controversial medical genius.

Blockbuster movies: In 2012-13, ION Television will continue to deliver movie hits including "Slumdog Millionaire," "Best in Show" and "Ali."

Original holiday movies: Double-digit increases among households, adults 18 to 49 and total viewers. Six new originals premiering in November and December.



Source: Nielsen Co. prime-time ratings—M-Su 7 p.m.-1 a.m. (excludes news, sports, kids networks). Top 10 network rankings based on C3 prime-time data for 1Q'12. Three-year percent growth data based on C3 prime-time impressions M-Su 7 p.m.-midnight for broadcast years 2008-09, 2009-10 and 2010-11. Percent live viewing compares all original scripted cable series' first-run episodes during prime time, January-December 2011. Top 10 key spending categories based on MRI Spring 2011 Study.